INT'L GROUP plans to participate in the auction for 100% equity of Huatuo Pharmaceutical to enhance market share
I'm PortAI, I can summarize articles.
INT'L GROUP announced that its wholly-owned subsidiary, Zhejiang INT'L Pharmaceutical Co., Ltd., intends to participate in the auction for 100% equity of Huadong Pharmaceutical through the Zhejiang Property Exchange, with a listing reserve price of 369 million yuan. This move aims to enhance the company's market share and industry concentration in Zhejiang Province, strengthen its bargaining power with upstream suppliers, and promote the company's high-quality development
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments